Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 1,163,417 |
|
|||||
| News | - | ||||||
| Day High | 18.00 | Low High |
|||||
| Day Low | 17.13 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Day One Biopharmaceuticals Inc | DAWN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.32 | -1.82% | 17.25 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 18.00 | 17.13 | 18.00 | 17.17 | 17.57 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,376 | 1,163,417 | US$ 17.45 | US$ 20,295,882 | - | 9.67 - 18.0699 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:47:01 | average | 1,300 | US$ 17.715 | USD |
Day One Biopharmaceuticals (DAWN) Options Flow Summary
Day One Biopharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.5B | 87.38M | - | 0 | -188.92M | -2.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Day One Biopharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DAWN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 13.3098 | 18.0699 | 13.2291 | 16.29 | 1,903,680 | 3.94 | 29.60% |
| 1 Month | 14.02 | 18.0699 | 13.02 | 15.45 | 1,697,084 | 3.23 | 23.04% |
| 3 Months | 15.25 | 18.0699 | 13.02 | 15.43 | 1,067,385 | 2.00 | 13.11% |
| 6 Months | 12.12 | 18.0699 | 10.90 | 14.70 | 784,824 | 5.13 | 42.33% |
| 1 Year | 14.01 | 18.0699 | 9.67 | 13.62 | 904,652 | 3.24 | 23.13% |
| 3 Years | 25.00 | 28.699 | 5.44 | 15.58 | 674,223 | -7.75 | -31.00% |
| 5 Years | 25.00 | 28.699 | 5.44 | 15.58 | 674,223 | -7.75 | -31.00% |
Day One Biopharmaceuticals Description
| Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The lead product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. |
